Editorial: For $10,000, you get ...
By Sacramento Bee,
Sacramento Bee
| 04. 16. 2006
Frustrated by lawsuits that have held up funding for California's $3 billion stem cell research institute, some of San Francisco's most prominent philanthropists are holding a gala fundraiser for this state agency on May 22.
A press release for "Reach for Tomorrow, Research Today" says the event will offer "private scientific briefings" and "private tours" of nearby campuses for donors willing to contribute up to $10,000 per person, or $100,000 per table. The event also offers a VIP reception, a black-tie dinner and appearances by actress Julie Andrews, composer Marvin Hamlisch and others.
Presumably, the event will also draw university deans and biotech executives who want some exclusive face time with institute leaders - public officials who will be deciding on multi-million-dollar grants to universities and biotech companies. At least three of these public officials are helping to organize the event. These include Institute President Zach Hall, Oversight Committee Chairman Robert Klein II and Vice Chairman Ed Penhoet, listed as honorary co-chairs of "Reach for Tomorrow." (Details can be found at www.reachfortomorrow.info.)
What is wrong with this picture? Plenty, if...
Related Articles
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Emily Mullin, Wired | 03.23.2026
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...